Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration

Abstract

Issues caused by maxillofacial tumours involve not only dealing with tumours but also repairing jaw bone defects. In traditional tumour therapy, the systemic toxicity of chemotherapeutic drugs, invasive surgical resection, intractable tumour recurrence, and metastasis are major threats to the patients’ lives in the clinic. Fortunately, biomaterial-based intervention can improve the efficiency of tumour treatment and decrease the possibility of recurrence and metastasis, suggesting new promising antitumour therapies. In addition, maxillofacial bone tissue defects caused by tumours and their treatment can negatively affect the physiological and psychological health of patients, and investment in treatment can result in a multitude of burdens to society. Biomaterials are promising options because they have good biocompatibility and bioactive properties for stimulation of bone regeneration. More interestingly, an integrated material regimen that combines tumour therapy with bone repair is a promising treatment option. Herein, we summarized traditional and biomaterial-mediated maxillofacial tumour treatments and analysed biomaterials for bone defect repair. Furthermore, we proposed a promising and superior design of dual-functional biomaterials for simultaneous tumour therapy and bone regeneration to provide a new strategy for managing maxillofacial tumours and improve the quality of life of patients in the future.

References

[1] Speight PM, Takata T. New tumor entities in the 4th edition of the World Health Organization Classification of Head and Neck tumors: odontogenic and maxillofacial bone tumors. Virchows Arch.: Int. J. Pathol., 2018, 472: 331-339.

[2] Ettinger KS, Ganry L, Fernandes RP. Oral cavity cancer. Oral. Maxillofac. Surg. Clin. North Am., 2019, 31: 13-29.

[3] Ettinger KS, Yetzer JG. Controversies in oral and maxillofacial oncology. Oral. Maxillofac. Surg. Clin. North Am., 2017, 29: 487-501.

[4] Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin. Proc., 2016, 91: 386-396.

[5] Bray F, . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer J. clinicians, 2018, 68: 394-424.

[6] Rajendra Santosh AB, Ogle OE. Odontogenic tumors. Dent. Clin. North Am., 2020, 64: 121-138.

[7] Sahoo NK, Choudhary AK, Srinivas V, Kapil T. Dermoid cysts of maxillofacial region. Med. J., Armed Forces India, 2015, 71: S389-S394.

[8] Peacock ZS. Adjunctive strategies for benign maxillofacial pathology. Oral. Maxillofac. Surg. Clin. North Am., 2019, 31: 569-578.

[9] Patel SY, Kim DD, Ghali GE. Maxillofacial reconstruction using vascularized fibula free flaps and endosseous implants. Oral. Maxillofac. Surg. Clin. North Am., 2019, 31: 259-284.

[10] de Casso C, Slevin N, Homer J. The impact of radiotherapy on swallowing and speech in patients who undergo total laryngectomy. Otolaryngol.–Head. Neck Surg., 2008, 139: 792-797.

[11] Jensdottir T, Buchwald C, Nauntofte B, Hansen H, Bardow A. Saliva in relation to dental erosion before and after radiotherapy. Acta Odontol. Scand., 2013, 71: 1008-1013.

[12] Mowery A, Light T, Clayburgh D. Long-term trends in head and neck surgery outcomes. Otolaryngol.–Head. Neck Surg., 2018, 159: 1012-1019.

[13] De Sousa A. Psychological issues in oral and maxillofacial reconstructive surgery. Br. J. Oral. Maxillofac. Surg., 2008, 46: 661-664.

[14] Suzuki M, . Anxiety and depression in patients after surgery for head and neck cancer in Japan. Palliat. supportive care, 2016, 14: 269-277.

[15] Nizzero S, Shen H, Ferrari M, Corradetti B. Immunotherapeutic transport oncophysics: space, time, and immune activation in cancer. Trends cancer, 2020, 6: 40-48.

[16] Gorbet M, Ranjan A. Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: recent progress and challenges in treatment and tracking response to immunotherapy. Pharmacol. therapeutics, 2020, 207: 107456.

[17] Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct. Target. Ther., 2018, 3: 7.

[18] Yang Z, . Advances in nanomaterials for use in photothermal and photodynamic therapeutics (Review). Mol. Med. Rep., 2019, 20: 5-15.

[19] Ngwa W, . Smart Radiation Therapy Biomaterials. Int. J. Radiat. Oncol., Biol., Phys., 2017, 97: 624-637.

[20] Tong R, Kohane DS. New strategies in cancer nanomedicine. Annu. Rev. Pharmacol. Toxicol., 2016, 56: 41-57.

[21] He J, . Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment. Adv. Mater., 2019, 31

[22] Sun Z, Song C, Wang C, Hu Y, Wu J. Hydrogel-based controlled drug delivery for cancer treatment: a review. Mol. pharmaceutics, 2020, 17: 373-391.

[23] Visscher D, . Advances in bioprinting technologies for craniofacial reconstruction. Trends Biotechnol., 2016, 34: 700-710.

[24] Alvarez C, . Osteoimmunology of oral and maxillofacial diseases: translational applications based on biological mechanisms. Front. Immunol., 2019, 10: 1664.

[25] Taylor G, Miller G, Ham F. The free vascularized bone graft. A clinical extension of microvascular techniques. Plast. Reconstructive Surg., 1975, 55: 533-544.

[26] Hidalgo D. Fibula free flap: a new method of mandible reconstruction. Plast. Reconstructive Surg., 1989, 84: 71-79.

[27] Momoh A, . A prospective cohort study of fibula free flap donor-site morbidity in 157 consecutive patients. Plast. reconstructive Surg., 2011, 128: 714-720.

[28] Chen T, . Promotion of osseointegration using protamine/alginate/bone morphogenic protein 2 biofunctionalized composite coating on nanopolymorphic titanium surfaces. J. Biomed. Nanotechnol., 2018, 14: 933-945.

[29] Lin Y, . Calcium phosphate cement scaffold with stem cell co-culture and prevascularization for dental and craniofacial bone tissue engineering. Dent. Mater., 2019, 35: 1031-1041.

[30] Covello P, Buchbinder D. Recent trends in the treatment of benign odontogenic tumors. Curr. Opin. Otolaryngol. head. neck Surg., 2016, 24: 343-351.

[31] Kerawala C, Roques T, Jeannon J, Bisase B. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J. Laryngol. Otol., 2016, 130: S83-S89.

[32] Avon SL, Klieb HB. Oral soft-tissue biopsy: an overview. J. Can. Dent. Assoc., 2012, 78: c75.

[33] Handschel J, . CT-scan is a valuable tool to detect mandibular involvement in oral cancer patients. Oral. Oncol., 2012, 48: 361-366.

[34] McMahon J, . Postoperative risk stratification in oral squamous cell carcinoma. Br. J. Oral. Maxillofac. Surg., 2020, 58: 462-468.

[35] Wu J, . Camptothecin@HMSNs/thermosensitive hydrogel composite for applications in preventing local breast cancer recurrence. Chin. Chem. Lett., 2018, 29: 1819-1823.

[36] Gong B, Morris MD. Raman spectroscopy monitors adverse bone sequelae of cancer radiotherapy. Chin. Chem. Lett., 2015, 26: 401-406.

[37] de Carvalho, P. et al. Three Photobiomodulation Protocols in the Prevention/Treatment of Radiotherapy-induced Oral Mucositis. Photodiagnosis and photodynamic therapy, 101906, https://doi.org/10.1016/j.pdpdt.2020.101906 (2020).

[38] Srivastava S, Negi P, Chopra D, Misra S. Maxillary reservoir denture to overcome radiation-induced xerostomia-Light at the end of the tunnel. J. cancer Res. therapeutics, 2020, 16: 693-696.

[39] Li X, . Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy. Head. neck, 2019, 41: 3525-3534.

[40] Sim F, Leidner R, Bell RB. Immunotherapy for head and neck cancer. Oral. Maxillofac. Surg. Clin. North Am., 2019, 31: 85-100.

[41] Yang JS, . Suppression of the TNF-alpha level is mediated by Gan-Lu-Yin (traditional Chinese medicine) in human oral cancer cells through the NF-kappa B, AKT, and ERK-dependent pathways. Environ. Toxicol., 2016, 31: 1196-1205.

[42] Farmer ZL, Kim ES, Carrizosa DR. Gene therapy in head and neck cancer. Oral. Maxillofac. Surg. Clin. North Am., 2019, 31: 117-124.

[43] Bu L-L, . Advances in drug delivery for post-surgical cancer treatment. Biomaterials, 2019, 219: 119182.

[44] Qi M, . Enhanced in vitro and in vivo anticancer properties by using a nanocarrier for co-delivery of antitumor polypeptide and curcumin. J. Biomed. Nanotechnol., 2018, 14: 139-149.

[45] Li R, . Facile Optimization and Evaluation of PEG-PCL block copolymeric nanoparticles for anticancer drug delivery using copolymer hybrids and histoculture drug response assays. J. Biomed. Nanotechnol., 2018, 14: 321-330.

[46] Zhang E, Xing R, Liu S, Li P. Current advances in development of new docetaxel formulations. Expert Opin. drug Deliv., 2019, 16: 301-312.

[47] Gupta P, . Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer. Int J. Nanomed., 2018, 13: 67-69.

[48] Wu D, . Chitosan-based colloidal polyelectrolyte complexes for drug delivery: a review. Carbohydr. Polym., 2020, 238: 116126.

[49] Ashrafizadeh M, . Chitosan-based advanced materials for docetaxel and paclitaxel delivery: recent advances and future directions in cancer theranostics. Int. J. Biol. macromolecules, 2020, 145: 282-300.

[50] Cacciotti I, . Controlled release of 18-β-glycyrrhetic acid by nanodelivery systems increases cytotoxicity on oral carcinoma cell line. Nanotechnology, 2018, 29: 285101.

[51] Lan X, . Microneedle-Mediated Delivery of Lipid-Coated Cisplatin Nanoparticles for Efficient and Safe Cancer Therapy. ACS Appl. Mater. interfaces, 2018, 10: 33060-33069.

[52] Xian C, Yuan Q, Bao Z, Liu G, Wu J. Progress on intelligent hydrogels based on RAFT polymerization: Design strategy, fabrication and the applications for controlled drug delivery. Chin. Chem. Lett., 2020, 31: 19-27.

[53] Norouzi M, Nazari B, Miller DW. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov. today, 2016, 21: 1835-1849.

[54] Tan, B., Huang, L., Wu, Y. & Liao, J. Advances and trends of hydrogel therapy platform in localized tumor treatment: a review. J. Biomed. Mater. Res. A, https://doi.org/10.1002/jbm.a.37062 (2020).

[55] Karavasili C, . Synergistic antitumor potency of a self-assembling peptide hydrogel for the local co-delivery of doxorubicin and curcumin in the treatment of head and neck cancer. Mol. Pharmaceutics, 2019, 16: 2326-2341.

[56] Nasrin A, Hassan M, Gomes V. Two-photon active nucleus-targeting carbon dots: enhanced ROS generation and photodynamic therapy for oral cancer. Nanoscale, 2020

[57] Graciano T, . Using chitosan gels as a toluidine blue O delivery system for photodynamic therapy of buccal cancer: In vitro and in vivo studies. Photodiagnosis Photodyn. Ther., 2015, 12: 98-107.

[58] Li Q, . Sulphur-doped carbon dots as a highly efficient nano-photodynamic agent against oral squamous cell carcinoma. Cell Prolif., 2020, 53

[59] Lawen A. Apoptosis-an introduction. BioEssays: N. Rev. Mol., Cell. developmental Biol., 2003, 25: 888-896.

[60] Wang D, . Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer. ACS Nano, 2014, 8: 6620-6632.

[61] Moosavi Nejad S, . Acute effects of sono-activated photocatalytic titanium dioxide nanoparticles on oral squamous cell carcinoma. Ultrason. Sonochem., 2016, 32: 95-101.

[62] Wang J, . Detection and analysis of reactive oxygen species (ROS) generated by nano-sized TiO2 powder under ultrasonic irradiation and application in sonocatalytic degradation of organic dyes. Ultrason Sonochem., 2011, 18: 177-183.

[63] Yamaguchi S, . Sonodynamic therapy using water-dispersed TiO₂-polyethylene glycol compound on glioma cells: comparison of cytotoxic mechanism with photodynamic therapy. Ultrason. Sonochem., 2011, 18: 1197-1204.

[64] Tachibana K, . Enhanced mechanical damage to in vitro cancer cells by high-intensity-focused ultrasound in the presence of microbubbles and titanium dioxide. J. Med. Ultrason., 2015, 42: 449-455.

[65] Vankayala R, Hwang K. Near-infrared-light-activatable nanomaterial-mediated phototheranostic nanomedicines: an emerging paradigm for cancer treatment. Adv. Mater., 2018, 30

[66] Gilchrist R, . Selective inductive heating of lymph nodes. Ann. Surg., 1957, 146: 596.

[67] Legge C, Colley H, Lawson M, Rawlings A. Targeted magnetic nanoparticle hyperthermia for the treatment of oral cancer. J. Oral. Pathol. Med., 2019, 48: 803-809.

[68] Xiong J, . SDF-1-loaded PLGA nanoparticles for the targeted photoacoustic imaging and photothermal therapy of metastatic lymph nodes in tongue squamous cell carcinoma. Int. J. Pharmaceutics, 2019, 554: 93-104.

[69] Wang M, . Reactive oxygen species and near-infrared light dual-responsive indocyanine green-loaded nanohybrids for overcoming tumor multidrug resistance. Eur. J. Pharm. Sci., 2019, 134: 185-193.

[70] Won AM, Montgomery P, Aponte-Wesson R, Chambers M. Implant-supported and magnet-retained oral-nasal combination prosthesis in a patient with a total rhinectomy and partial maxillectomy due to cancer: a clinical report. J. Prosthet. Dent., 2017, 117: 315-320.

[71] Zschöck-Holle A, Reik M, Wölfle O, Sauerbier M. Treatment of basal joint osteoarthritis by Swanson’s trapezium implant arthroplasty. Handchirurgie, Mikrochirurgie, plastische Chirurgie: Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie: Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse: Organ der V.…, 2015, 47: 7-16.

[72] Lee W, . Mandibular reconstruction with a ready-made type and a custom-made type titanium mesh after mandibular resection in patients with oral cancer. Maxillofac. Plast. reconstructive Surg., 2018, 40

[73] Ogino A, Onishi K, Nakamichi M. Primary reconstruction after maxillectomy defects using ultra flex mesh plate and rectus abdominis myocutaneous free flap including aponeurosis of external abdominal oblique muscle. J. Craniofacial Surg., 2019, 30: 211-213.

[74] Cristofolini L. A critical analysis of stress shielding evaluation of hip prostheses. Crit. Rev. Biomed. Eng., 1997, 25: 409-483.

[75] Lorenz J, Al-Maawi S, Sader R, Ghanaati S. Individualized titanium mesh combined with platelet-rich fibrin and deproteinized bovine bone: a new approach for challenging augmentation. J. Oral. Implantol., 2018, 44: 345-351.

[76] Wu, C. et al. Surface modification of titanium with collagen/hyaluronic acid and bone morphogenetic protein 2/7 heterodimer promotes osteoblastic differentiation. Dental Materials Journal, https://doi.org/10.4012/dmj.2019-249 (2020).

[77] Li X, . A magnesium-incorporated nanoporous titanium coating for rapid osseointegration. Int. J. Nanomed., 2020, 15: 6593-6603.

[78] Du Y, Guo J, Wang J, Mikos A, Zhang S. Hierarchically designed bone scaffolds: from internal cues to external stimuli. Biomaterials, 2019, 218: 119334.

[79] Mazzoni E, . Hydroxylapatite-collagen hybrid scaffold induces human adipose-derived mesenchymal stem cells to osteogenic differentiation in vitro and bone regrowth in patients. Stem cells Transl. Med., 2020, 9: 377-388.

[80] U V, Mehrotra D, Howlader D, Kumar S, Anand V. Bone marrow aspirate in cystic maxillofacial bony defects. J. Craniofac Surg., 2019, 30: e247-e251.

[81] Aguilar, A. et al. Application of Chitosan in Bone and Dental Engineering. Molecules (Basel, Switzerland) 24, https://doi.org/10.3390/molecules24163009 (2019).

[82] Demirtaş TT, Irmak G, Gümüşderelioğlu M. A bioprintable form of chitosan hydrogel for bone tissue engineering. Biofabrication, 2017, 9: 035003.

[83] Ishiko-Uzuka R, . Oriented bone regenerative capacity of octacalcium phosphate/gelatin composites obtained through two-step crystal preparation method. J. Biomed. Mater. Res B Appl Biomater., 2017, 105: 1029-1039.

[84] Koca C, Komerik N, Ozmen O. Comparison of efficiency of hyaluronic acid and/or bone grafts in healing of bone defects. Niger. J. Clin. Pract., 2019, 22: 754-762.

[85] Prins H, Schulten E, Ten Bruggenkate C, Klein-Nulend J, Helder M. Bone regeneration using the freshly isolated autologous stromal vascular fraction of adipose tissue in combination with calcium phosphate ceramics. Stem Cells Transl. Med., 2016, 5: 1362-1374.

[86] Raucci M, . Antimicrobial imidazolium ionic liquids for the development of minimal invasive calcium phosphate-based bionanocomposites. ACS Appl. Mater. interfaces, 2018, 10: 42766-42776.

[87] Xu, Z. et al. Poly(Dopamine) coating on 3D-printed poly-lactic-co-glycolic acid/β-tricalcium phosphate scaffolds for bone tissue engineering. Molecules (Basel, Switzerland) 24, https://doi.org/10.3390/molecules24234397 (2019).

[88] Li Y, . An effective dual-factor modified 3D-printed PCL scaffold for bone defect repair. J. Biomed. Mater. Res B Appl. Biomater., 2020, 108: 2167-2179.

[89] Davies J, Matta R, Mendes V, Perri de Carvalho P. Development, characterization and clinical use of a biodegradable composite scaffold for bone engineering in oro-maxillo-facial surgery. Organogenesis, 2010, 6: 161-166.

[90] Mastrogiacomo M, . Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials, 2006, 27: 3230-3237.

[91] Zakaria S, Sharif Zein S, Othman M, Yang F, Jansen J. Nanophase hydroxyapatite as a biomaterial in advanced hard tissue engineering: a review. Tissue Eng. Part B, Rev., 2013, 19: 431-441.

[92] Bai, Y. et al. Comparison of the bone regenerative capacity of three-dimensional uncalcined and unsintered hydroxyapatite/Poly-d/l-lactide and beta-tricalcium phosphate used as bone graft substitutes. J. Investig. Surg., 1–14, https://doi.org/10.1080/08941939.2019.1616859 (2019).

[93] Habraken WJ, Wolke JG, Mikos AG, Jansen JA. Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J. Biomater. Sci. Polym. Ed., 2006, 17: 1057-1074.

[94] Park, S. Y., Kim, K. H., Kim, S., Lee, Y. M. & Seol, Y. J. BMP-2 gene delivery-based bone regeneration in dentistry. Pharmaceutics 11, https://doi.org/10.3390/pharmaceutics11080393 (2019).

[95] Salazar VS, Gamer LW, Rosen V. BMP signalling in skeletal development, disease and repair. Nat. Rev. Endocrinol., 2016, 12: 203-221.

[96] Li F, . Evaluation of recombinant human FGF-2 and PDGF-BB in periodontal regeneration: a systematic review and meta-analysis. Sci. Rep., 2017, 7

[97] Friedlaender GE, Lin S, Solchaga LA, Snel LB, Lynch SE. The role of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in orthopaedic bone repair and regeneration. Curr. Pharm. Des., 2013, 19: 3384-3390.

[98] Hankenson K, Gagne K, Shaughnessy M. Extracellular signaling molecules to promote fracture healing and bone regeneration. Adv. drug Deliv. Rev., 2015, 94: 3-12.

[99] Boda SK, . Mineralized nanofiber segments coupled with calcium-binding BMP-2 peptides for alveolar bone regeneration. Acta Biomater., 2019, 85: 282-293.

[100] Kim HK, . Osteogenesis induced by a bone forming peptide from the prodomain region of BMP-7. Biomaterials, 2012, 33: 7057-7063.

[101] Sheikh Z, . Achieving enhanced bone regeneration using monetite granules with bone anabolic drug conjugates (C3 and C6) in rat mandibular defects. J. Biomed. Mater. Res. B Appl. Biomater., 2020, 108: 2670-2680.

[102] Fang D, Long Z, Hou J. Clinical application of concentrated growth factor fibrin combined with bone repair materials in jaw defects. J. Oral. Maxillofac. Surg., 2020, 78: 882-892.

[103] Qiao J, An N, Ouyang X. Quantification of growth factors in different platelet concentrates. Platelets, 2017, 28: 774-778.

[104] Zhang L, Ai H. Concentrated growth factor promotes proliferation, osteogenic differentiation, and angiogenic potential of rabbit periosteum-derived cells in vitro. J. Orthop. Surg. Res., 2019, 14

[105] Zheng Z-w, . Development of an accurate and proactive immunomodulatory strategy to improve bone substitute material-mediated osteogenesis and angiogenesis. Theranostics, 2018, 8: 5482.

[106] Bruder SP, . Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J. Orthop. Res., 1998, 16: 155-162.

[107] Petite H, . Tissue-engineered bone regeneration. Nat. Biotechnol., 2000, 18: 959-963.

[108] Bhattacharya I, Ghayor C, Weber F. The use of adipose tissue-derived progenitors in bone tissue engineering: a review. Transfus. Med. Hemotherapy: Offizielles Organ der Dtsch. Ges. fur Transfusionsmedizin und Immunhamatologie, 2016, 43: 336-343.

[109] Mao S, Chen C, Chen C. Osteogenic potential of induced pluripotent stem cells from human adipose-derived stem cells. Stem Cell Res. Ther., 2019, 10: 303.

[110] Kim D, . Effect of different concentration of demineralized bone powder with gellan gum porous scaffold for the application of bone tissue regeneration. Int. J. Biol. Macromolecules, 2019, 134: 749-758.

[111] Sharpe PT. Dental mesenchymal stem cells. Development, 2016, 143: 2273-2280.

[112] Song Y, . Engineering bone regeneration with novel cell-laden hydrogel microfiber-injectable calcium phosphate scaffold. Mater. Sci. Eng. C., Mater. Biol. Appl., 2017, 75: 895-905.

[113] Ginebra M, Driessens F, Planell J. Effect of the particle size on the micro and nanostructural features of a calcium phosphate cement: a kinetic analysis. Biomaterials, 2004, 25: 3453-3462.

[114] Khurana K, . Injectable calcium phosphate foams for the delivery of Pitavastatin as osteogenic and angiogenic agent. J. Biomed. Mater. Res. Part B, Appl. Biomater., 2020, 108: 760-770.

[115] Ginebra M, Canal C, Espanol M, Pastorino D, Montufar E. Calcium phosphate cements as drug delivery materials. Adv. Drug Deliv. Rev., 2012, 64: 1090-1110.

[116] Ambard A, Mueninghoff L. Calcium phosphate cement: review of mechanical and biological properties. J. Prosthodont., 2006, 15: 321-328.

[117] Naudot M, . Functional validation of a new alginate-based hydrogel scaffold combined with mesenchymal stem cells in a rat hard palate cleft model. Plast. Reconstructive Surg. Glob. Open, 2020, 8

[118] Xu F, . Development of biodegradable bioactive glass ceramics by DLP printed containing EPCs/BMSCs for bone tissue engineering of rabbit mandible defects. J. Mech. Behav. Biomed. Mater., 2020, 103: 103532.

[119] Gjerde C, . Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial. Stem cell Res. Ther., 2018, 9: 213.

[120] Bouler JM, Pilet P, Gauthier O, Verron E. Biphasic calcium phosphate ceramics for bone reconstruction: a review of biological response. Acta Biomater., 2017, 53: 1-12.

[121] Brini AT, . Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel. Expert Opin. Drug Deliv., 2016, 13: 789-798.

[122] Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD. Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie, 2013, 95: 2235-2245.

[123] Guo X, Oshima H, Kitmura T, Taketo MM, Oshima M. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J. Biol. Chem., 2008, 283: 19864-19871.

[124] Yang X, . Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2. Vitr. Cell. developmental Biol. Anim., 2013, 49: 270-278.

[125] LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett., 2003, 195: 127-137.

[126] Siddiqui, H., Pickering, K. & Mucalo, M. A review on the use of hydroxyapatite-carbonaceous structure composites in bone replacement materials for strengthening purposes. Materials (Basel, Switzerland) 11, https://doi.org/10.3390/ma11101813 (2018).

[127] Murata T, . Evaluation of a new hydroxyapatite nanoparticle as a drug delivery system to oral squamous cell carcinoma cells. Anticancer Res., 2018, 38: 6715-6720.

[128] Zhang K, . Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect. Sci. Adv., 2019, 5

[129] Ma H, Feng C, Chang J, Wu C. 3D-printed bioceramic scaffolds: from bone tissue engineering to tumor therapy. Acta Biomater., 2018, 79: 37-59.

[130] Ma H, . 3D printing of biomaterials with mussel-inspired nanostructures for tumor therapy and tissue regeneration. Biomaterials, 2016, 111: 138-148.

[131] Ma H, . A bifunctional biomaterial with photothermal effect for tumor therapy and bone regeneration. Adv. Funct. Mater., 2016, 26: 1197-1208.

[132] Johnson A, . Therapeutic effects of antibiotics loaded cellulose nanofiber and κ-carrageenan oligosaccharide composite hydrogels for periodontitis treatment. Sci. Rep., 2020, 10

[133] Chen Z, . Injectable and self-healing hydrogel with anti-bacterial and anti-inflammatory properties for acute bacterial rhinosinusitis with micro invasive treatment. Adv. Healthc. Mater., 2020, 9

[134] Zhu Y, . Injectable pH and redox dual responsive hydrogels based on self-assembled peptides for anti-tumor drug delivery. Biomater. Sci., 2020, 8: 5415-5426.

[135] Ding, X. et al. Synthetic peptide hydrogels as 3D scaffolds for tissue engineering. Adv. Drug Delivery Rev., https://doi.org/10.1016/j.addr.2020.10.005 (2020).

[136] Luo S, . An injectable, bifunctional hydrogel with photothermal effects for tumor therapy and bone regeneration. Macromol. Biosci., 2019, 19

[137] Tagami T, Yoshimura N, Goto E, Noda T, Ozeki T. Fabrication of muco-adhesive oral films by the 3d printing of hydroxypropyl methylcellulose-based catechin-loaded formulations. Biol. Pharm. Bull., 2019, 42: 1898-1905.

[138] Z, Y., Z, X., X, S. & J, T. Local delivery of sunitinib and Ce6 via redox-responsive zwitterionic hydrogels effectively prevents osteosarcoma recurrence. Journal of Mater. Chem. B, https://doi.org/10.1039/d0tb00970a (2020).

[139] Yang D, . The immune reaction and degradation fate of scaffold in cartilage/bone tissue engineering. Mater. Sci. Eng. C., Mater. Biol. Appl., 2019, 104: 109927.

[140] Konings H, . A literature review of the potential diagnostic biomarkers of head and neck neoplasms. Front Oncol., 2020, 10: 1020.

[141] Liao J, . Hyaluronan based tumor-targeting and PH-responsive shell cross-linkable nanoparticles for the controlled release of doxorubicin. J. Biomed. Nanotechnol., 2018, 14: 496-509.

[142] Wu Z, . Tumor microenvironment-response calcium phosphate hybrid nanoparticles enhanced siRNAs targeting tumors invivo. J. Biomed. Nanotechnol., 2018, 14: 1816-1825.

[143] Glenske, K. et al. Applications of metals for bone regeneration. Int. J. Mol. Sci. 19, https://doi.org/10.3390/ijms19030826 (2018).

[144] Özyazgan İ. Septal deviation treatment using bone or cartilage grafts fixed with cyanoacrylate tissue adhesive. Aesthetic Plast. Surg., 2017, 41: 618-627.

[145] Xu J, . pH-sensitive deoxycholic acid dimer for improving doxorubicin delivery and antitumor activity in vivo. Colloids Surf. B, Biointerfaces, 2020, 196: 111319.

[146] Soltantabar P, Calubaquib E, Mostafavi E, Biewer M, Stefan M. Enhancement of loading efficiency by coloading of doxorubicin and quercetin in thermoresponsive polymeric micelles. Biomacromolecules, 2020, 21: 1427-1436.

[147] Abou-El-Naga A, Mutawa G, El-Sherbiny I, Mousa S. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells. Int. J. Nanomed., 2018, 13: 8153-8164.

[148] Oyaneder-Terrazas J, Polanco C, Figueroa D, Barriga A, García C. In vitro biotransformation of OA-group and PTX-group toxins in visceral and non-visceral tissues of and. Food Addit. Contam. Part A, Chem., Anal., control, exposure risk Assess., 2020, 37: 1216-1228.

[149] Mardas N, Dereka X, Donos N, Dard M. Experimental model for bone regeneration in oral and cranio-maxillo-facial surgery. J. Invest Surg., 2014, 27: 32-49.

[150] Chao Y, . Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumomstscr responses. Nat. Biomed. Eng., 2018, 2: 611-621.

[151] van Gemert JTM, . Early and late complications in the reconstructed mandible with free fibula flaps. J. surgical Oncol., 2018, 117: 773-780.

[152] Breeze J, . Health-related quality of life after maxillectomy: obturator rehabilitation compared with flap reconstruction. Br. J. Oral. Maxillofac. Surg., 2016, 54: 857-862.

[153] Freudlsperger C, Bodem JP, Engel E, Hoffmann J. Mandibular reconstruction with a prefabricated free vascularized fibula and implant-supported prosthesis based on fully three-dimensional virtual planning. J. Craniofac Surg., 2014, 25: 980-982.

[154] Xu H, . Reconstruction of anterior mandible and mouth floor using the myofascial iliac crest free flap after tumor resection. Ann. Plast. Surg., 2019, 82: 411-414.

[155] Peng WM, . Bionic mechanical design and 3D printing of novel porous Ti6Al4V implants for biomedical applications. J. Zhejiang Univ. Sci. B, 2019, 20: 647-659.

[156] Sanz M, . Biomaterials and regenerative technologies used in bone regeneration in the craniomaxillofacial region: consensus report of group 2 of the 15th European Workshop on Periodontology on Bone Regeneration. J. Clin. Periodontol., 2019, 46(Suppl 21): 82-91.

[157] Brie J, . A new custom made bioceramic implant for the repair of large and complex craniofacial bone defects. J. Cranio-Maxillo-Facial Surg.: Off. Publ. Eur. Assoc. Cranio-Maxillo-Facial Surg., 2013, 41: 403-407.

Funding

the National Natural Science Foundation (31972925), Sichuan Science and Technology Program (2020YJ0065), Sichuan University Spark Project (2018SCUH0029), State Key Laboratory of Oral Diseases Foundation (SKLOD202016)

Undergraduate Innovation and Entrepreneurship Training Program of Sichuan University (C2020108331)